Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Analytical methods for therapeutic drug monitoring and toxicology / / Q. Alan Xu, Timothy L. Madden
| Analytical methods for therapeutic drug monitoring and toxicology / / Q. Alan Xu, Timothy L. Madden |
| Autore | Xu Quanyun A. <1961-> |
| Pubbl/distr/stampa | Hoboken, N.J., : Wiley, c2011 |
| Descrizione fisica | 1 online resource (518 p.) |
| Disciplina | 615/.19 |
| Altri autori (Persone) | MaddenTimothy L |
| Soggetto topico |
Drugs - Analysis
Drugs - Toxicity testing |
| ISBN |
9786612904806
9780470922798 0470922796 9781282904804 1282904809 9780470909782 0470909781 9780470909799 047090979X |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
ANALYTICAL METHODS FOR THERAPEUTIC DRUGMONITORING AND TOXICOLOGY; CONTENTS; Preface; MONOGRAPHS; Abacavir; Abecarnil; Acamprosate Calcium; Acebutolol Hydrochloride; Aceclofenac; Acemetacin; Acenocoumarol; Acetaminophen; Acetazolamide; Aconitine; Acrivastine; Acyclovir; Albendazole; Albuterol; Alcuronium Chloride; Alfentanil Hydrochloride; Alfuzosin Hydrochloride; Allobarbital; Allopurinol; Alprazolam; Alprenolol; Ambroxol Hydrochloride; Amikacin; Amiloride Hydrochloride; Amiodarone Hydrochloride; Amisulpride; Amitriptyline Hydrochloride; Amlodipine Besylate; Amobarbital; Amoxapine
AmoxicillinAmphetamine; Amphotericin B; Ampicillin; Amprenavir; Amsacrine; Apomorphine Hydrochloride; Aripiprazole; Arotinolol Hydrochloride; Artemisinin; Artesunate; Aspirin; Atazanavir Sulfate; Atenolol; Azathioprine; Azithromycin; Baclofen; Barbital; Benactyzine Hydrochloride; Bendroflumethiazide; Benzthiazide; Benzylpenicillin Potassium; Betaxolol Hydrochloride; Biapenem; Bisoprolol Fumarate; Bromazepam; Bromisoval; Bromperidol; Brompheniramine Maleate; Buflomedil Hydrochloride; Bumetanide; Buparvaquone; Bupivacaine Hydrochloride; Buprenorphine; Bupropion Hydrochloride Buspirone HydrochlorideBusulfan; Caffeine; Candesartan Cilexetil; Canrenone; Capecitabine; Capreomycin Sulfate; Carbamazepine; Carbidopa; Carbinoxamine Maleate; Carboplatin; Carbromal; Carteolol Hydrochloride; Carvedilol; Caspofungin Acetate; Cathine; Cefaclor; Cefadroxil; Cefalexin; Cefazolin Sodium; Cefdinir; Cefditoren Pivoxil; Cefepime Hydrochloride; Cefixime; Cefotaxime Sodium; Cefozopran Hydrochloride; Cefpiramide; Cefpirome Sulfate; Cefpodoxime Proxetil; Cefprozil; Ceftazidime; Ceftibuten; Ceftiofur Hydrochloride; Ceftizoxime Sodium; Ceftriaxone Sodium; Cefuroxime; Celecoxib Celiprolol HydrochlorideCephalexin Hydrochloride; Cetirizine Hydrochloride; Chloramphenicol; Chlordiazepoxide; Chlorhexidine Acetate; Chlorothiazide; Chlorphenamine Maleate; Chlorpromazine; Chlorpropamide; Chlorthalidone; Cilnidipine; Cimetidine; Ciprofloxacin; Cisapride; Cisplatin; Citalopram Hydrobromide; Clarithromycin; Clavulanate Potassium; Clemastine Fumarate; Clenbuterol Hydrochloride; Clinafloxacin Hydrochloride; Clobazam; Clofazimine; Clomipramine Hydrochloride; Clonazepam; Clonidine; Clopamide; Cloperastine; Clotiapine; Cloxacillin; Clozapine; Cocaine; Codeine; Cotinine CyclopenthiazideCyclophosphamide; Cyclosporine; Cyproheptadine Hydrochloride; Cytarabine; Dabigatran Etexilate; Dapsone; Daptomycin; Darunavir; Debrisoquine Sulfate; Decitabine; Delavirdine Mesylate; Derxazoxane; Desipramine Hydrochloride; Desloratadine; Dexamethasone; Dexfenfluramine Hydrochloride; Dextromethorphan Hydrobromide; Dextromoramide Tartrate; Diamorphine Hydrochloride; Diazepam; Dibenzepin Hydrochloride; Diclofenac Sodium; Diclofenamide; Dicloxacillin Sodium; Didanosine; Digoxin; Diltiazem Hydrochloride; Dimethylformamide; Dimethylsulfoxide; Diphemanil Metilsulfate Diphenhydramine Hydrochloride |
| Record Nr. | UNINA-9910133588903321 |
Xu Quanyun A. <1961->
|
||
| Hoboken, N.J., : Wiley, c2011 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Pharmaceutical toxicology in practice [[electronic resource] ] : a guide for non-clinical development / / edited by Alberto Lodola, Jeanne Stadler
| Pharmaceutical toxicology in practice [[electronic resource] ] : a guide for non-clinical development / / edited by Alberto Lodola, Jeanne Stadler |
| Pubbl/distr/stampa | Hoboken, N.J., : John Wiley & Sons, c2011 |
| Descrizione fisica | 1 online resource (268 p.) |
| Disciplina | 615/.7040724 |
| Altri autori (Persone) |
LodolaAlberto
StadlerJeanne |
| Soggetto topico | Drugs - Toxicity testing |
| ISBN |
0-470-92272-9
1-283-07223-8 9786613072238 0-470-90991-9 0-470-90990-0 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | The regulatory environment / Claudio Bernardi and Marco Brughera --Toxicological development : roles and responsibilities / Franck Chuzel and Bernard Ruty -- Contract research organizations / Maurice Cary -- Safety pharmacology / Claudio Arrigoni and Valeria Perego -- Formulations, impurities and toxicokinetics / Claude Charuel -- General toxicology / Alberto Lodola -- Genetic toxicology / Peggy Guzzie-Peck, Jennifer Sasaki, and Sandy Weiner -- Developmental and reproductive toxicology / Jeanne Stadler -- Data analysis, report writing and regulatory documentation / Monique Y. Wells -- Risk management / Alberto Lodola. |
| Record Nr. | UNINA-9910141014803321 |
| Hoboken, N.J., : John Wiley & Sons, c2011 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Pharmaceutical toxicology in practice : a guide for non-clinical development / / edited by Alberto Lodola, Jeanne Stadler
| Pharmaceutical toxicology in practice : a guide for non-clinical development / / edited by Alberto Lodola, Jeanne Stadler |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | Hoboken, N.J., : John Wiley & Sons, c2011 |
| Descrizione fisica | 1 online resource (268 p.) |
| Disciplina | 615/.7040724 |
| Altri autori (Persone) |
LodolaAlberto
StadlerJeanne |
| Soggetto topico | Drugs - Toxicity testing |
| ISBN |
9786613072238
9780470922729 0470922729 9781283072236 1283072238 9780470909911 0470909919 9780470909904 0470909900 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | The regulatory environment / Claudio Bernardi and Marco Brughera --Toxicological development : roles and responsibilities / Franck Chuzel and Bernard Ruty -- Contract research organizations / Maurice Cary -- Safety pharmacology / Claudio Arrigoni and Valeria Perego -- Formulations, impurities and toxicokinetics / Claude Charuel -- General toxicology / Alberto Lodola -- Genetic toxicology / Peggy Guzzie-Peck, Jennifer Sasaki, and Sandy Weiner -- Developmental and reproductive toxicology / Jeanne Stadler -- Data analysis, report writing and regulatory documentation / Monique Y. Wells -- Risk management / Alberto Lodola. |
| Record Nr. | UNINA-9910811438303321 |
| Hoboken, N.J., : John Wiley & Sons, c2011 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Preclinical development handbook Toxicology [[electronic resource] /] / [edited by] Shayne Cox Gad
| Preclinical development handbook Toxicology [[electronic resource] /] / [edited by] Shayne Cox Gad |
| Pubbl/distr/stampa | Hoboken, NJ, : Wiley-Interscience, c2008 |
| Descrizione fisica | 1 online resource (1075 p.) |
| Disciplina |
615.7
615.7040724 615.9 |
| Altri autori (Persone) | GadShayne C. <1948-> |
| Collana | Pharmaceutical Development Series |
| Soggetto topico |
Drugs - Toxicology
Drugs - Toxicity testing |
| ISBN |
1-281-23742-6
9786611237424 0-470-24905-6 0-470-24904-8 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
PRECLINICAL DEVELOPMENT HANDBOOK Toxicology; CONTRIBUTORS; CONTENTS; Preface; 1 Preclinical Drug Development Planning; 2 Use of Project Teams in Preclinical Development; 3 Relationship between Animal Models and Clinical Research: Using Mucositis as a Practical Example; 4 Bacterial Mutation Assay; 5 In Vitro Mammalian Cell Mutation Assays; 6 In Vitro Mammalian Cytogenetic Tests; 7 In Vivo Genotoxicity Assays; 8 Repeat Dose Toxicity Studies; 9 Irritation and Local Tissue Tolerance Studies in Pharmacetical Safety Assessment; 10 Safety Assessment Studies: Immunotoxicity
11 Immunotoxicity Testing: ICH Guideline S8 and Related Aspects12 Reproductive and Developmental Toxicology; 13 Carcinogenicity Studies; 14 Toxicokinetics: An Integral Component of Preclinical Toxicity Studies; 15 In Vitro Toxicokinetics and Dynamics: Modeling and Interpretation of Toxicity Data; 16 Toxicologic Pathology; 17 Secondary Pharmacodynamic Studies and In Vitro Pharmacological Profiling; 18 Current Practices in Safety Pharmacology; 19 Safety Assessment of Biotechnology-Derived Therapeutics; 20 Preclinical Development of Protein Pharmaceuticals: An Overview 21 The Pharmacogenomics of Personalized Medicine22 Genomics; 23 Proteomics; 24 Toxicogenomics in Preclinical Development; 25 Toxicoproteomics: Preclinical Studies; 26 Regulatory Considerations; 27 Regulatory Issues in Preclinical Safety Studies (U.S. FDA); 28 Selection and Utilization of CROs for Safety Assessment; 29 Auditing and Inspecting Preclinical Research and Compliance with Good Laboratory Practice (GLP); 30 Drug Impurities and Degradants and Their Safety Qualification; 31 Bridging Studies in Preclinical Pharmaceutical Safety Assessment; Index |
| Record Nr. | UNINA-9910784842603321 |
| Hoboken, NJ, : Wiley-Interscience, c2008 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
